From antimicrobial to anticancer: unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers.
- DOI
- 10.3389/fphar.2024.1340029
- Published
- 2024
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2024.1340029,
title = {From antimicrobial to anticancer: unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers.},
author = {Piktel E and Wnorowska U and Gorbacz-Konończuk J and Sienkiewicz J and Głuszek K and Okła S and Bucki R},
year = {2024},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2024.1340029},
url = {https://doi.org/10.3389/fphar.2024.1340029}
}RIS
TY - JOUR TI - From antimicrobial to anticancer: unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers. AU - Piktel E AU - Wnorowska U AU - Gorbacz-Konończuk J AU - Sienkiewicz J AU - Głuszek K AU - Okła S AU - Bucki R PY - 2024 JO - Frontiers in pharmacology DO - 10.3389/fphar.2024.1340029 UR - https://doi.org/10.3389/fphar.2024.1340029 ER -
APA
E, P., U, W., J, G., J, S., K, G., S, O., & R, B. (2024). From antimicrobial to anticancer: unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2024.1340029
Source records
- pubmed · retrieved 2026-11-10T20:32:21.370Z